DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Dasatinib
Dasatinib
Management of Chronic Myelogenous Leukemia in Pregnancy
The Effects of Combination Treatments on Drug Resistance in Chronic Myeloid Leukaemia: an Evaluation of the Tyrosine Kinase Inhibitors Axitinib and Asciminib H
Sprycel
Combinatorial Efficacy of Entospletinib and Chemotherapy in Patient-Derived Xenograft Models of Infant Acute Lymphoblastic Leukemia
Antibody–Drug Conjugates: the Last Decade
2021 Formulary List of Covered Prescription Drugs
Activity of Dasatinib, a Dual SRC/ABL Kinase Inhibitor, and IPI-504, A
Hypopigmentation of the Skin and Hair Associated with Targetedclinical Therapies and BIOMEDICAL INVESTIGATION
The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer Thomas C
Revisiting Clinical Trials Using EGFR Inhibitor-Based
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy
Ado-Trastuzumab Emtansine: Drug Information
Targeted Therapy–Based Combination Treatment in Rhabdomyosarcoma Anke E.M
Kinase Drug Discovery 20 Years After Imatinib: Progress and Future Directions
Axitinib and Sorafenib Are Potent in Tyrosine Kinase Inhibitor Resistant
2012 NIOSH List of Antineoplastic and Other Hazardous Drugs
Phase II Trial of Dasatinib for Patients with Acquired Resistance To
Bladder Cancer
Top View
Starting on SPRYCEL® (Dasatinib) TABLE of CONTENTS
Tyrosine Kinase Inhibitor Family of Drugs As Prospective Targeted Therapy for COVID-19 Based on in Silico and 3D-Human Vascular Lung Model Studies
1. Gershenson, David.Pptx
Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: a Focus on Transporters and Lysosomal Sequestration
Volume 7 Issue 3
A Case Study of Kinase Inhibitors
Phase Ib Study of Nivolumab and Dasatinib in Patients with Relapsed/Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Pulmonary Arterial Hypertension Associated with Protein Kinase Inhibitors: a Pharmacovigilance- Pharmacodynamic Study
Negative HNSCC – Alteration of EGFR and VEGFR-2 Expression in Vitro
Antibody Conjugation of Nanoparticles As Therapeutics for Breast Cancer Treatment
Efficacy and Safety of Dasatinib with Trastuzumab and Paclitaxel in First Line HER2-Positive Metastatic Breast Cancer: Results from the Phase II GEICAM/2010-04 Study
Gynecomastia in a Male After Dasatinib Treatment for Chronic Myeloid Leukemia
Adult Antiemetic Management of Chemotherapy-Induced Nausea
Survey of Ex Vivo Drug Combination Effects in Chronic Lymphocytic Leukemia Reveals Synergistic Drug Effects and Genetic Dependencies
Alberto Ocaña Hospital Clínico San Carlos Madrid Centro Regional De Investigaciones Biomédicas
Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation
Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk
Oncology Agents Policy #: Rx.01.67